Fukushima K - Search Results

1

Three kinds of antibacterial substances from Lentinus edodes (Berk.) Sing. (Shiitake, an edible mushroom).

Hirasawa M, Shouji N, Neta T, Fukushima K, Takada K. Hirasawa M, et al. Among authors: fukushima k. Int J Antimicrob Agents. 1999 Feb;11(2):151-7. doi: 10.1016/s0924-8579(98)00084-3. Int J Antimicrob Agents. 1999. PMID: 10221419

2

Anticaries effect of a component from shiitake (an edible mushroom).

Shouji N, Takada K, Fukushima K, Hirasawa M. Shouji N, et al. Among authors: fukushima k. Caries Res. 2000 Jan-Feb;34(1):94-8. doi: 10.1159/000016559. Caries Res. 2000. PMID: 10601791

3

Production, characterization, and application of monoclonal antibodies which distinguish four glucosyltransferases from Streptococcus sobrinus.

Nanbu A, Hayakawa M, Takada K, Shinozaki N, Abiko Y, Fukushima K. Nanbu A, et al. Among authors: fukushima k. FEMS Immunol Med Microbiol. 2000 Jan;27(1):9-15. doi: 10.1111/j.1574-695X.2000.tb01405.x. FEMS Immunol Med Microbiol. 2000. PMID: 10617784 Free article.

4

Effects of certain salts on glucosyltransferase synthesis by Streptococcus mutans strain PS-14.

Takada K, Fukushima K. Takada K, et al. Among authors: fukushima k. J Dent Res. 1986 Mar;65(3):452-5. doi: 10.1177/00220345860650031601. J Dent Res. 1986. PMID: 2937821

5

Three-layered microcapsules as a long-term sustained release injection preparation.

Ito Y, Ochii Y, Fukushima K, Sugioka N, Takada K. Ito Y, et al. Among authors: fukushima k. Int J Pharm. 2010 Jan 15;384(1-2):53-9. doi: 10.1016/j.ijpharm.2009.09.032. Epub 2009 Sep 25. Int J Pharm. 2010. PMID: 19782737

6

Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats.

Fukushima K, Haraya K, Terasaka S, Ito Y, Sugioka N, Takada K. Fukushima K, et al. Biol Pharm Bull. 2008 Jun;31(6):1209-14. doi: 10.1248/bpb.31.1209. Biol Pharm Bull. 2008. PMID: 18520056 Free article.

7

Pharmacokinetics of human immunodeficiency virus protease inhibitor, nelfinavir, in poloxamer 407-induced hyperlipidemic model rats.

Sugioka N, Haraya K, Maeda Y, Fukushima K, Takada K. Sugioka N, et al. Among authors: fukushima k. Biol Pharm Bull. 2009 Feb;32(2):269-75. doi: 10.1248/bpb.32.269. Biol Pharm Bull. 2009. PMID: 19182388 Free article.

8

Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory rats.

Sugioka N, Haraya K, Fukushima K, Ito Y, Takada K. Sugioka N, et al. Among authors: fukushima k. Biopharm Drug Dispos. 2009 Dec;30(9):532-41. doi: 10.1002/bdd.689. Biopharm Drug Dispos. 2009. PMID: 19862765

9

Self-dissolving micropile array chip as percutaneous delivery system of protein drug.

Ito Y, Hasegawa R, Fukushima K, Sugioka N, Takada K. Ito Y, et al. Among authors: fukushima k. Biol Pharm Bull. 2010;33(4):683-90. doi: 10.1248/bpb.33.683. Biol Pharm Bull. 2010. PMID: 20410606 Free article.

10

Permeation enhancement of ascorbic acid by self-dissolving micropile array tip through rat skin.

Ito Y, Maeda T, Fukushima K, Sugioka N, Takada K. Ito Y, et al. Among authors: fukushima k. Chem Pharm Bull (Tokyo). 2010 Apr;58(4):458-63. doi: 10.1248/cpb.58.458. Chem Pharm Bull (Tokyo). 2010. PMID: 20410623 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,599 results

Search Page

Filters